Sanofi

For the period ended Dec 31, 2025. Filed Feb 17, 2026.

About this filing

The yearly report of a company based outside the US. It covers much of what a 10-K does, and may follow accounting rules other than US ones.

FY2025 · Filed Feb 17, 2026

SNY$47.04+0.3%Stored close · as of Nov 6, 2026

Contents

Item 16B. Code of Ethics

We have adopted a code of ethics (hereafter the "Code of Conduct"), as defined in Item 16B. of Form 20-F under the Exchange

Act, containing specific rules relating to financial ethics. Our Code of Conduct applies to our Chief Executive Officer, Chief

Financial Officer, Chief Accounting Officer and other officers performing similar functions, as designated from time to time. Our

Code of Conduct was amended on September 29, 2025 and this amended version is available on our website at www.sanofi.com

(information on our website is not incorporated by reference of this annual report). The main changes consisted in the addition of

a new chapter on health and safety, and in strengthening commitments regarding inclusion, environmental protection and

intellectual property protection. A copy of our Code of Conduct may also be obtained free of charge by addressing a written

request to the attention of Individual Shareholder Relations at our headquarters in Paris. We will disclose any future amendments

to the provisions of such financial Code of Conduct on our website.

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.